Lupus Nephritis
Overview
Authors
Affiliations
Childhood-onset systemic lupus erythematosus (SLE) is a subset of SLE with an onset before 18 years of age. Patients with early onset SLE tend to have a greater genetic component to their disease cause, more multisystemic involvement, and a more severe disease course, which includes greater risks for developing nephritis and end-stage kidney disease. Five- and 10-year mortality is lower than in adult-onset SLE. Although patient and renal survival have improved with advances in induction and maintenance immunosuppression, accumulation of irreversible damage is common. Cardiovascular and infectious complications are frequent, as are relapses during adolescence and the transition to adulthood.
Progress of rituximab in the treatment of systemic lupus erythematosus and lupus nephritis.
Mo S, Li Y, He J, Lin L Front Med (Lausanne). 2024; 11:1472019.
PMID: 39430591 PMC: 11486751. DOI: 10.3389/fmed.2024.1472019.
Biologicals for the treatment of lupus nephritis: a Bayesian network meta-regression analysis.
Liu X, Chen X, Yang C, Li R, Chen X, Li Q Front Immunol. 2024; 15:1445814.
PMID: 39281677 PMC: 11392858. DOI: 10.3389/fimmu.2024.1445814.
Li Y, Yang J, Zhang Y, Cao Y, Li X, Shuai L Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(8):835-839.
PMID: 39148388 PMC: 11334543. DOI: 10.7499/j.issn.1008-8830.2404159.
Remission and long-term remission of pediatric-onset systemic lupus erythematosus.
Chen Y, Hsu C, Tsai M, Fu L, Huang Y Front Pediatr. 2023; 11:1272065.
PMID: 37964813 PMC: 10641753. DOI: 10.3389/fped.2023.1272065.
Jiang N, Jin S, Yu C, Zhao J, Wang Q, Tian X Front Immunol. 2023; 14:1232244.
PMID: 37901212 PMC: 10611487. DOI: 10.3389/fimmu.2023.1232244.